
Nutra Pharma Announces Manufacturing Alliance With Omnia Biologics to Produce RPI-78M for Clinical Trials in Pediatric Multiple ...
Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus ( …